World Congress on Precision Biotherapeutics - 2026
The World Congress on Precision Biotherapeutics (WCPB 2026) is proud to partner with leading global pharmaceutical companies, biotech innovators, diagnostic developers, and biomanufacturing leaders advancing precision medicine worldwide.
Pioneering targeted biopharmaceutical delivery through next-generation site-specific enzymatic antibody-drug conjugates (ADCs) and novel topoisomerase I payloads for oncology clinical programs.
Global leader in ionizable lipid nanoparticle (LNP) molecular transport systems, extrahepatic mRNA organ targeting, and synthetic oligonucleotides for monogenic disease therapies.
Companion diagnostic (CDx) assays, liquid biopsy ctDNA biomarker profiling, and master clinical trial protocols.
Precision base editing tools, off-the-shelf allogeneic CAR-NK cells, and viral capsid tropism engineering.
Continuous bioprocessing systems, Quality by Design (QbD) regulatory compliance, and GMP scale-up facility solutions.
Actinium-225 bioconjugates & PET/SPECT dosimetry.
Generative AI structural protein modeling & molecular docking.
Global cryogenic storage & cell therapy shipping infrastructure.
High-throughput analytical DAR & mass spec characterization.
Connect with our Industry Relations Secretariat to reserve your exhibition booth, keynote symposia, or custom sponsorship package.